Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Oscar Norbeck"'
Autor:
Lars Ohrmalm, Michelle Wong, Carl Aust, Per Ljungman, Oscar Norbeck, Kristina Broliden, Thomas Tolfvenstam
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e36543 (2012)
BACKGROUND: Until recently, viral infections in patients with hematological malignancies were concerns primarily in allogeneic hematopoietic stem cell transplant (HSCT) recipients. During the last years, changed treatment regimens for non-transplante
Externí odkaz:
https://doaj.org/article/dcbd35e1011e418180b35b7ea2bafdd6
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e46430 (2012)
The recently discovered human parvovirus 4 (PARV4) has been associated with seropositivity for human immunodeficiency virus, hepatitis B virus and hepatitis C virus. High prevalence is seen especially in intravenous drug users. The virus has been det
Externí odkaz:
https://doaj.org/article/21ff6834365947ed8f1a37d0a8d6d632
Autor:
Adiba Isa, Victoria Kasprowicz, Oscar Norbeck, Andrew Loughry, Katie Jeffery, Kristina Broliden, Paul Klenerman, Thomas Tolfvenstam, Paul Bowness
Publikováno v:
PLoS Medicine, Vol 2, Iss 12, p e343 (2005)
Human parvovirus B19 (B19) is a ubiquitous and clinically significant pathogen, causing erythema infectiosum, arthropathy, transient aplastic crisis, and intrauterine fetal death. The phenotype of CD8+ T cells in acute B19 infection has not been stud
Externí odkaz:
https://doaj.org/article/7dca08f3570844c7af3b229fb76a581b
Autor:
Björn Owe-Larsson, Anna Häggmark-Månberg, David Just, Daniel X. Johansson, Arasch Zandian, Hanna Nilsson, Jochen M. Schwenk, Cecilia Hellström, Louise Wingard, Oscar Norbeck, Peter Nilsson, Mats A. A. Persson, Mathias Uhlén, Evelina Sjöstedt
Publikováno v:
Schizophrenia Bulletin
Background Immunological reactions may have a role in subgroups of patients suffering from psychiatric disorders. Possible markers for such subgroups may be autoantibodies of currently unknown nature. If identified, they could indicate which patients
Autor:
Adiba Isa, Oscar Norbeck, Taha Hirbod, Anders Lundqvist, Victoria Kasprowicz, Paul Bowness, Paul Klenerman, Kristina Broliden, Thomas Tolfvenstam
Publikováno v:
Journal of Medical Virology; Jan2006, Vol. 78 Issue 1, p129-133, 0p
Publikováno v:
Karolinska Institutet
Parvovirus B19 is known to cause fetal death in the second trimester, mainly in combination with hydrops fetalis. However, the frequency of parvovirus-B19-associated non-hydropic fetal loss in the late second and third trimester has not been thorough
Autor:
Susanne Wolf, Bo Johansson, Anna Lindblom, Adiba Isa, Thomas Tolfvenstam, Oscar Norbeck, Kristina Broliden
Publikováno v:
Karolinska Institutet
Lindblom, A, Isa, A, Norbeck, O, Wolf, S, Johansson, B, Broliden, K & Tolfvenstam, T 2005, ' Slow clearance of human parvovirus B19 viremia following acute infection. ', Clinical Infectious Diseases, vol. 41, no. 8, pp. 1201-3 . https://doi.org/10.1086/444503
Lindblom, A, Isa, A, Norbeck, O, Wolf, S, Johansson, B, Broliden, K & Tolfvenstam, T 2005, ' Slow clearance of human parvovirus B19 viremia following acute infection. ', Clinical Infectious Diseases, vol. 41, no. 8, pp. 1201-3 . https://doi.org/10.1086/444503
Udgivelsesdato: 2005-Oct-15 Parvovirus B19 is a common, clinically significant pathogen. Reassessment of the viral kinetics after acute infection showed that the virus is not rapidly cleared from healthy hosts, despite early resolution of symptoms. T
Autor:
Anna Lindblom, Tove Kaldensjö, Oscar Norbeck, Kristina Broliden, Thomas Tolfvenstam, Igge Gustafsson, Jan-Inge Henter
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 50(10)
Autor:
Anna Lindblom, Oscar Norbeck, Igge Gustafsson, Åsa Vernby, Mats Heyman, Tove Kaldensjö, Jan-Inge Henter, Kristina Broliden, Thomas Tolfvenstam
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(4)
BACKGROUND Parvovirus B19 infection causes severe cytopenia and can mimic a leukemic relapse or therapy-induced cytopenia in patients with hematologic malignancies. We evaluated the complications of parvovirus B19 infection, including delays in the s
Publikováno v:
Experimental hematology. 32(11)
Objective To evaluate the capacity of parvovirus B19 capsid protein VP2 to inhibit hematopoiesis in vitro and in vivo. If effective, a VP2-derived construct may have therapeutic and prophylactic utility in diseases associated to overproduction of hem